Circulating miR-10b-5p drives Kawasaki vasculitis via endothelial reprogramming and nominates CXCL8 as an early diagnostic biomarker

Abstract Kawasaki disease (KD) is an acute systemic vasculitis and the leading cause of acquired heart disease in children, yet no specific biomarker enables early diagnosis at emergency department presentation. We aimed to define the molecular mechanisms driving KD vasculitis and to identify a clinically actionable early diagnostic marker. Whole microRNA sequencing of buffy coat specimens from patients with KD and febrile controls identified 68 upregulated microRNAs, of which 13 were prioritized. Candidates were validated in two KD-like vasculitis mouse models, and miR-10b-5p was consistently elevated. Inhibition of miR-10b-5p by a miRCURY locked nucleic acid inhibitor attenuated aortic root inflammation in vivo. In human coronary artery endothelial cells from adult donors, miR-10b-5p directly suppressed marker of proliferation Ki-67 ( MKI67 ) and chromobox 5 ( CBX5 ), driving a transition from proliferative and metabolic programs toward a proinflammatory phenotype, as confirmed by single-cell and bulk RNA sequencing. Chromatin accessibility profiling revealed increased accessibility at the C-X-C motif chemokine ligand 8 ( CXCL8 ) promoter, and motif analysis identified CCAAT enhancer binding protein alpha ( CEBPA ) as the key transcriptional activator; CEBPA knockdown abrogated miR-10b-5p-induced CXCL8 upregulation, and direct binding was confirmed by binding assays and chromatin immunoprecipitation. Serum CXCL8 was markedly elevated in patients with KD relative to febrile controls at first presentation before definitive diagnosis and declined significantly at the 8-week follow-up. Receiver operating characteristic analysis demonstrated diagnostic utility, with sensitivity and specificity of 83.3% at an optimal cut-off of 20.91 pg/ml. In conclusion, we define a miR-10b-5p– MKI67 / CBX5 –CEBPA–CXCL8 axis driving endothelial reprogramming and neutrophil-recruiting inflammation in KD and identify serum CXCL8 as a candidate biomarker for timely KD recognition.

Authors

Institutions

Publication Details

Journal
Experimental & Molecular Medicine
Published
2026-11-13
DOI
https://doi.org/10.1038/s12276-026-01887-w
Primary Topic
Kawasaki Disease and Coronary Complications
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Circulating miR-10b-5p drives Kawasaki vasculitis via endothelial reprogramming and nominates CXCL8 as an early diagnostic biomarker

Gaeun Kang, Woo‐Jae Park, Somy Yoon, Bitna Lim et al.
2 links
Experimental & Molecular Medicine
Kawasaki Disease and Coronary Complications
article

Circulating miR-10b-5p drives Kawasaki vasculitis via endothelial reprogramming and nominates CXCL8 as an early diagnostic biomarker

Gaeun Kang, Woo‐Jae Park, Somy Yoon, Bitna Lim, Young Kuk Cho, Gwang Hyeon Eom, Young‐Kook Kim, Min Hee Kim, Mira Kim, HyeonJin Yang, Sunyoung Park, Seunghoon Jung
article en

Abstract

Abstract Kawasaki disease (KD) is an acute systemic vasculitis and the leading cause of acquired heart disease in children, yet no specific biomarker enables early diagnosis at emergency department presentation. We aimed to define the molecular mechanisms driving KD vasculitis and to identify a clinically actionable early diagnostic marker. Whole microRNA sequencing of buffy coat specimens from patients with KD and febrile controls identified 68 upregulated microRNAs, of which 13 were prioritized. Candidates were validated in two KD-like vasculitis mouse models, and miR-10b-5p was consistently elevated. Inhibition of miR-10b-5p by a miRCURY locked nucleic acid inhibitor attenuated aortic root inflammation in vivo. In human coronary artery endothelial cells from adult donors, miR-10b-5p directly suppressed marker of proliferation Ki-67 ( MKI67 ) and chromobox 5 ( CBX5 ), driving a transition from proliferative and metabolic programs toward a proinflammatory phenotype, as confirmed by single-cell and bulk RNA sequencing. Chromatin accessibility profiling revealed increased accessibility at the C-X-C motif chemokine ligand 8 ( CXCL8 ) promoter, and motif analysis identified CCAAT enhancer binding protein alpha ( CEBPA ) as the key transcriptional activator; CEBPA knockdown abrogated miR-10b-5p-induced CXCL8 upregulation, and direct binding was confirmed by binding assays and chromatin immunoprecipitation. Serum CXCL8 was markedly elevated in patients with KD relative to febrile controls at first presentation before definitive diagnosis and declined significantly at the 8-week follow-up. Receiver operating characteristic analysis demonstrated diagnostic utility, with sensitivity and specificity of 83.3% at an optimal cut-off of 20.91 pg/ml. In conclusion, we define a miR-10b-5p– MKI67 / CBX5 –CEBPA–CXCL8 axis driving endothelial reprogramming and neutrophil-recruiting inflammation in KD and identify serum CXCL8 as a candidate biomarker for timely KD recognition.

Experimental & Molecular Medicine
Chonnam National University (KR), Ewha Womans University (KR), Chonnam National University Hospital (KR), Chonnam National University Hwasun Hospital (KR), Chonnam National University Children's Hospital (KR), Chung-Ang University (KR)
University of Ulsan, Korea Health Industry Development Institute, National Research Foundation of Korea, Ministry of Science and ICT, South Korea
Good health and well-being
Kawasaki Disease and Coronary Complications
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon